Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p469 | Other diseases of bone and mineral metabolism | ECTS2016

FGF23 and vitamin D metabolism in chronic kidney disease – mineral bone disorder

Piec Isabelle , Chipchase Allison , Nicholls Holly , Washbourne Christopher , Tang Jonathan , Fraser William D.

Fibroblast growth factor-23 (FGF23) is a major regulator of phosphate metabolism often elevated in genetic hypophosphataemic disorders and in chronic kidney disease–bone mineral disorder (CKD–BMD). Recent studies have identified relationships between FGF23 and vitamin D.Objectives: To determine the relationship between vitamin D and FGF23 metabolism in CKD.Method: We used randomized samples from patient...

ba0004p74 | (1) | ICCBH2015

A case of resistant hypophosphataemic rickets

Awogbemi Olumoyin , Safdar Asimah , McEnaney Rachel , Mahmood Nasim , Donne Adam , Weber Astrid , Dharmaraj Poonam

Background: Hypophosphataemic rickets (HPR) is an inherited condition of phosphate wasting associated with abnormal bone biochemistry and features of rickets. Most patients respond to treatment with alfacalcidol and oral phosphate. Raised levels of alkaline phosphatase (ALP) and parathyroid hormone (PTH) generally indicate a need for refining treatment, or poor compliance.Presenting problem: We report the case of a 36 week gestation male infant born to c...

ba0001es2.3 | Approach to the finding of abnormal laboratory results (<emphasis role="italic">Supported by Alexion &amp; IDS</emphasis>) | ECTS2013

Low vitamin D

Obermayer-Pietsch Barbara

Supported by Alexion & IDS)-->Low vitamin D serum levels have been associated with a considerable number of diseases and conditions and have attracted significant attention of the scientific community as well as of health authorities all over the world. However, discussions and controversies are ongoing about the reliability, significance and correct ranges of low vitamin D serum levels. A central goa...

ba0003pp327 | Osteoporosis: treatment | ECTS2014

Baseline data of the DEVIDE-study: DEnosumab vs Intravenous Ibandronate: a 2-year retrospective head to head real life study

Amrein Karin , Muschitz Christian , Wagner Doris , Pieber Thomas R , Resch Heinrich , Dimai Hans Peter , Fahrleitner-Pammer Astrid

Introduction: Effective treatment of postmenopausal osteoporosis (PMO) is frequently compromised by poor adherence to short-term (≤1-monthly) medications. Aim of this study is to investigate the effect of parenteral ibandronate (IBN) compared to denosumab in a cohort of IBN pretreated PMO patients.Methods: In a retrospective analysis, a total of 808 women were treated with quarterly 3 mg IBN injections for 27+3 months and were regularly mo...

ba0003pp287 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Vitamin D status in sunny Lebanon

Yaghi Yasser , Zaiour Wajih , Zaatari Ziad El , Abdallah Ahmad , Abdallah Khaled

Introduction and aim: Vitamin D plays an important role in bone growth. In children, low levels can cause rickets. In adults, low levels can lead to osteoporosis and fragility fractures. The aim of this survey was to get information about vitamin D levels in Lebanese population.Subjects and methods: Serum 25-hydroxy vitamin D level is considered to be the best indicator of vitamin D status. 13 000 subjects included in this study were coming for routine c...

ba0005p21 | Biochemical testing | ECTS2016

Profiles of 25 hydroxyvitamin D and its metabolites 24, 25-dihydroxyvitamin D and 1, 25-dihydroxyvitamin D in vitamin D3 supplementation studies

Tang Jonathan , Nicholls Holly , Dutton John , Piec Isabelle , Washbourne Christopher , Saleh L , Novak A , Close G , Macdonald H , Jackson S , Greeves J , Fraser William

Background: Vitamin D plays an important role in calcium and phosphate homeostasis. Circulating 25 hydroxyvitamin D [25(OH)D] is metabolised into its biologically active form 1,25-dihydroxyvitamin D [1,25-d(OH)D] by the actions of 1α hydroxylase, and into inactive 2metabolite 24,25-dihydroxyvitamin D [24,25-d(OH)D] by 24-hydroxylase. Recent studies suggest the production of 1,25-d(OH)D) from 25(OH)D is 24,25-d(OH)D dependent. Genetic mutations of CYP24A1 gene resulting in...

ba0007is7 | (1) | ICCBH2019

Effect of vitamin D on body composition

Weiler Hope A

In Canada, and many other countries, a vitamin D supplement of 400 IU/day is recommended for breastfed infants and staple foods are fortified with vitamin D in accordance with public health policy for the primary prevention of rickets. Both vitamin D receptors and 1-alpha hydroxylase enzymes are expressed in human muscle, implicating vitamin D status and metabolism in growth and development. In a randomized dose response study of vitamin D supplementation (400, 800, 1200, or 1...

ba0007is8 | (1) | ICCBH2019

Vitamin D in pregnancy and offspring immunology

Hawrylowicz Catherine , Hornsby Eve , Cheadle Charlotte , Pfeffer Paul , Laranjo Nancy , Cruikshank William , Tuzova Marina , Litonjua Augusto A , Weiss Scott T , Carey Vincent J , O'Connor George

Vitamin D deficiency in pregnancy is common, and is linked to increased risk of adverse outcomes including preterm birth, preeclampsia, infection, gestational diabetes and asthma. Vitamin D possesses well-recognized immunomodulatory functions, and programming of the immune system during foetal development can influence asthma-related risk factors and health outcomes in later life. We hypothesized that influencing vitamin D status during pregnancy would impact the immune profil...

ba0004p175 | (1) | ICCBH2015

Effect of baseline vitamin D status on serum 25(OH) D level and body composition in breastfed infants on vitamin D supplementation

Czech-Kowalska Justyna , Jaworski Maciej , Maksym Dorota , Nowakowska-Rysz Monika , Wygledowska Grazyna , Pawlus Beata , Zochowska Anna , Kornacka Maria , Dobrzanska Anna

Objectives: Vitamin D intake at a dose 400 IU/d is recommended for breastfed infants and is considered as sufficient. Vitamin D status is connected with bone mass and fat mass. We aimed to assess, if 400 IU/d has the same efficiency and impact on body composition in infants with different vitamin D status at birth (<20 ng/ml vs ≧20 ng/ml).Methods: 148 breastfed infants were supplemented with 400 IU/d of cholecalciferol up to 6 months of age. S...

ba0003ahp4 | Allied Health Professionals Session | ECTS2014

Vitamin D and bone health in the older patient

Lips Paul

Vitamin D deficiency is common in aging people and is associated with secondary hyperparathyroidism, bone loss, osteoporosis and fractures in epidemiological studies. Vitamin D3 is produced in the skin through u.v. irradiation of the sun in spring and summer, and it can also be obtained from food, especially fatty fish, such as herring or mackerel. Vitamin D is activated by liver and kidney. Its main action is stimulation of calcium absorption from the gut. Vitamin ...